2 members of Congress have disclosed 11 trades in Anika Therapeutics, Inc. (ANIK) since 2016: 7 purchases worth about $172.00K and 4 sales worth about $56.50K. The most active was Tom Malinowski, with 8 trades. The latest trade was made on Mar 2, 2020.
ANIK’s price and SPY’s, both as the change since the start of the range. A green triangle marks a day members bought ANIK, a red one a day they sold; hover for who and how much.
| # | Member | Trades | Buys | Sells | Bought (est.) | Sold (est.) | Net | Buys vs SPY | First Traded | Last Traded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Tom MalinowskiD-NJ | 8 | 5 | 3 | $131.50K | $24.00K | +$107.50K | -205.2% | Jul 29, 2019 | Mar 2, 2020 |
| 2 | James B. RenacciR-OH | 3 | 2 | 1 | $40.50K | $32.50K | +$8.00K | -281.1% | Dec 20, 2016 | Dec 10, 2018 |
| Owner | Type | Filing | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Tom MalinowskiD-NJ | ANIKAnika Therapeutics Inc. | Self | Buy | $1K–$15K | Feb 27, 2020 | Aug 26, 2021 | 546d late | -52.8% | -205.6% | |
| Tom MalinowskiD-NJ | ANIKAnika Therapeutics Inc. | Self | Buy | $1K–$15K | Feb 28, 2020 | Aug 26, 2021 | 545d late | -53.5% | -207.4% | |
| Tom MalinowskiD-NJ | ANIKAnika Therapeutics Inc. | Self | Sell (Partial) | $1K–$15K | Oct 29, 2019 | Aug 26, 2021 | 667d late | -71.2% | -219.3% | |
| Tom MalinowskiD-NJ | ANIKAnika Therapeutics Inc. | Self | Sell (Partial) | $1K–$15K | Jan 28, 2020 | Aug 26, 2021 | 576d late | -57.1% | -187.2% | |
| Tom MalinowskiD-NJ | ANIKAnika Therapeutics Inc. | Self | Sell (Partial) | $1K–$15K | Jul 29, 2019 | Aug 26, 2021 | 759d late | -63.6% | -213.1% | |
| Tom MalinowskiD-NJ | ANIKAnika Therapeutics Inc. | Self | Buy | $50K–$100K | Aug 1, 2019 | Aug 26, 2021 | 756d late | -64.6% | -219.7% | |
| Tom MalinowskiD-NJ | ANIKAnika Therapeutics Inc. | Self | Buy | $1K–$15K | Mar 2, 2020 | Mar 5, 2021 | 368d late | -54.4% | -197.7% | |
| Tom MalinowskiD-NJ | ANIKAnika Therapeutics Inc. | Self | Buy | $15K–$50K | Feb 26, 2020 | Mar 5, 2021 | 373d late | -54.1% | -195.5% | |
| James B. RenacciR-OH | ANIK(ANIK) ANIKA THERAPEUTICS INCORPORATED | Self | Sell | $15K–$50K | Dec 10, 2018 | Jan 2, 2019 | 23d | -38.9% | -223.7% | |
| James B. RenacciR-OH | ANIKANIKA THERAPEUTICS INCORPORATED | Self | Buy | $1K–$15K | Jun 28, 2017 | Jul 7, 2017 | 9d | -60.8% | -269.7% | |
| James B. RenacciR-OH | ANIK(ANIK) ANIKA THERAPEUTICS INCORPORATED | Self | Buy | $15K–$50K | Dec 20, 2016 | Jan 5, 2017 | 16d | -60.3% | -292.5% |
Tip. Hover a row for the filing’s full asset text and comments; the PDF link opens the report itself.
2 members of Congress have disclosed 11 trades in Anika Therapeutics, Inc. (ANIK) since 2016: 7 purchases worth about $172.00K and 4 sales worth about $56.50K. The most active was Tom Malinowski, with 8 trades. The latest trade was made on Mar 2, 2020. Most active: Tom Malinowski (8), James B. Renacci (3).
Since 2016 they have disclosed 7 purchases and 4 sales; by the midpoints of the disclosed ranges, about $172.00K bought and $56.50K sold, a net purchase of $115.50K.
Members of Congress report each trade over $1,000 within 45 days under the STOCK Act, with the amount as a range. The chart marks the days members traded ANIK on its price, against the S&P 500 over the same days.
Members of Congress disclose trades as dollar ranges, up to 45 days after the trade and sometimes later. Volumes use the midpoints of those ranges and are estimates; portfolio figures are a model built from the disclosed trades, not the members’ actual accounts. Not investment advice.